CNTA Earnings Centessa Pharmaceuticals Plc
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.52 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | -1.46 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -0.98 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.57 | 2025-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.20 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | -2.06 | 2026-03-31 | 10-K |
| Q3 2025 | 2024-09-30 | -1.15 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.78 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.38 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -1.57 | 2025-03-24 | 10-K |
| Q3 2024 | 2023-09-30 | -1.20 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.80 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.53 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | -2.31 | 2024-03-28 | 10-K |
| Q3 2023 | 2022-09-30 | -1.86 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.29 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.60 | 2023-05-12 | 10-Q |
| FY 2022 | 2021-12-31 | -5.07 | 2023-03-30 | 10-K |
| Q3 2022 | 2021-09-30 | -4.60 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -4.89 | 2022-08-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.